Preventive care is increasing worldwide majorly after the Covid-19 pandemic, which is focused on curative care. A recent survey of over 1,000 individuals reveals that at least 40 percent of the respondents are highly inclined toward preventive health.
With technology disruption and new age technologies like Artificial Intelligence (AI), Machine Learning (ML), and the Internet of Things (IoT), preventive care has seen a revolution in terms of accuracy and speed, especially after the pandemic. Moreover, diagnostic tests are the only method to intervene at the appropriate time with the availability and accessibility of a wide range of a variety of tests.
Besides, the latest trends in preventive care are marked by an increasing level of awareness in Tier-II and III cities. Apart from the pandemic effect, the growing penetration of the internet, increasing use of mobile phones, and the 5G rollout in India most recently have put the spotlight on smaller towns and cities. Preventive care has made early detection of diseases like cancer, cardiovascular diseases, diabetes, and hypertension possible.
Various chronic and lifestyle diseases remain undiagnosed, contributing to the ever-growing health crisis. This gap presents an opportunity for tech based solutions to not only manage and treat diseases but also diagnose and prevent them.
The proliferation of healthcare data, driven by the increasing use of wearables, along with advances in machine learning (ML) and AI, has enabled the development of sophisticated solutions in that promise data-driven chronic disease risk assessment and diagnosis.
Post-COVID-19, a significant shift in consumer behavior is evident. For instance, according to a survey conducted by Kalaari Capital, it states that 70% of Indians prioritize overall health and precautionary measures in their daily routines.
By 2026, a doubling in per capita spending on health foods is anticipated, with consumers showing willingness to pay more for healthier options. Additionally, the government has increased healthcare budgets, emphasizing initiatives to enhance healthcare infrastructure and encourage healthier lifestyles.
| Attribute | Detail |
|---|---|
| Global Preventive Healthcare Technologies and Services Market Drivers |
|
The growing demand for technological advancements in healthcare systems and self-monitoring devices is significantly driving the preventive healthcare technologies and services market. Moreover, advanced healthcare infrastructure and systems integrate emerging technologies like telemedicine, electronic health records, and artificial intelligence, which in turn has resulted in preventive care to more accessible and efficient.
These systems provide proactive monitoring and early detection of potential health issues, which is generating awareness among patients to seek preventive care. For instance, in October 2023, OCHIN, a nonprofit leader in equitable health care innovation, started offering OCHIN Epic to rural hospitals nationwide.
With four hospitals already live on the new system and five more onboarding across six states, OCHIN's entrance into acute care helps ensure smaller hospitals can seamlessly connect care for their patients and recruit new talent using clinicians' electronic health records (EHR) platform of choice.
Similarly, in August 2023, The Royal Flying Doctor Service (RFDS), Australia’s rural and remote health services provider, launched a new nationwide Electronic Health Record (EHR) powered by Oracle Autonomous
Database, running on Oracle Cloud Infrastructure (OCI), to streamline clinical information collection and analysis leading to faster and better decision-making by medical staff. By moving to the cloud, RFDS has reduced administrative workloads and lowered its data management costs by approximately 20 percent.
Favorable government policies and initiatives focused at rise in social awareness about vaccination across governmental and non-governmental organizations (NGOs) play a crucial role in fueling the preventive healthcare technologies and services market.
Governments’ policies encouraging vaccination campaigns result in a higher demand for vaccine distribution, storage, and tracking technologies. The focus on immunization to prevent infectious diseases boosts growth in technologies like cold chain logistics, automated vaccine monitoring systems, and data analytics tools for immunization tracking.
For instance, in August 2024, A Zero Dose Implementation Plan 2024 was developed for 143 districts in 11 States in India that have a high number of unvaccinated children, as mentioned by Health Minister J.P. Nadda on Friday, August 9, 2024.
The Early detection and screening technologies segment is dominating the global FFPE preventive healthcare technologies and services market owing to several key factors. The rapidly increasing incidence and mortality of cancer calls for a focused effort to increase the effect of cancer‐prevention efforts.
In the area of early detection, there are major differences in the preventive impact of implemented screening policies, even when solid, evidence‐based international recommendations are issued. Studies are needed to determine why evidence‐based interventions are not used and to investigate why effects are less than predicted by solid research on the subject.
Moreover, several institutes are expanding their early screening technologies across the globe. For instance, in December 2023, Dana-Farber Cancer Institute is launching a first-of-its-kind, integrated clinic to increase early detection of precancerous conditions and to prevent cancer from arising in individuals at increased risk for the disease.
The new Centers for Early Detection and Interception at Dana-Farber bring together clinicians and researchers across many cancer types with a shared focus on precursor and hereditary conditions that can be early indicators of blood cancers and solid tumors.
The Centers for Early Detection will focus on developing novel technologies and methods for earlier cancer detection, as well as innovative ways to proactively intervene before a cancer fully develops or progresses.
The immunization segment is dominating the global preventive healthcare technologies and services market owing to growing vaccination campaigns, advancements in vaccine technology, increased education and awareness. Moreover, over the past five decades, vaccines have saved at least 154 million lives, according to the World Health Organization.
Diseases like smallpox have been eradicated, and polio is on the brink of elimination, thanks to widespread immunization efforts. According to research by the Office of Health Economics earlier this year, adult vaccination programmes can return up to 19 times their initial investment.
An approach that looks to first prevent disease should, by definition, include the implementation of successful immunization campaigns. It should also go hand in hand with fostering an environment that supports the development of new vaccine technologies.
Vaccine technology continues to evolve alongside the science. Various vaccine platforms can more effectively target a range of diseases and enhance future protection against diverse pathogens. To combat COVID-19, various vaccine technologies were successful in providing effective protection against the virus, including mRNA technology, which was used successfully for the first time.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
The rise in the number of launches preventive healthcare technologies and services by market players are expected to significantly propel North America’s growth over the forecast period. For instance, in December 2024, Apollo Cancer Centre (ACC) launched “LungLife Screening Programme” for early detection of lung cancer.
Through this, ACC aims to identify high-risk individuals early using low-dose computed tomography (LDCT) technology. The North America’s preventive healthcare technologies and services market is experiencing significant growth due to a combination of factors, including technological advancements, regulatory support, high healthcare spending, and a strong focus on preventive care.
North America is at the forefront of developing and adopting advanced diagnostic technologies, such as AI-driven imaging, genomic testing, and point-of-care (POC) diagnostics, which enhance early detection and disease management. The region has seen a rapid expansion of telehealth and mobile health (mHealth) services, making healthcare more accessible and convenient for patients.
For instance, in September 2023, the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services (HHS), announced the launch of ARPANET-H, a nationwide health innovation network anchored by three ARPA-H regional hubs.
The hubs will be mission-focused, accompanied by regional centers with a growing network of spokes from around the country representing the diversity of people, settings, and capabilities that encompass the American health ecosystem.
As global preventive healthcare technologies and services market providers are constantly innovating to improve product capabilities, innovative therapeutics are being introduced.
Abbott, Medtronic plc, GSK plc, Omron Healthcare, Inc., Merck and Co. Inc., Pfizer, Inc., Healthways, Inc., Mckesson Corporation, Myriad Genetics, Novx Systems, Inc., Quest Diagnostics Incorporated, and the other prominent players are the prominent preventive healthcare technologies and services market players.
Each of these players has been have been profiled in the preventive healthcare technologies and services market research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
| Attribute | Detail |
|---|---|
| Size in 2023 | US$ 260.2 Bn |
| Forecast Value in 2034 | More than US$ 773.1 Bn |
| CAGR | 10.6% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2023 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
The global preventive healthcare technologies and services market was valued at US$ 260.2 Bn in 2023.
Preventive healthcare technologies and services business is projected to cross US$ 773.1 Bn by the end of 2034.
The CAGR is anticipated to be 10.6% from 2024 to 2034.
North America is expected to account for the largest share from 2024 to 2034.
Abbott, Medtronic plc, GSK plc, Omron Healthcare, Inc., Merck and Co. Inc., Pfizer, Inc., Healthways, Inc., Mckesson Corporation, Myriad Genetics, Novx Systems, Inc., Quest Diagnostics Incorporated, and the other prominent players.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Preventive Healthcare Technologies and Services Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Preventive Healthcare Technologies and Services Market Analysis and Forecasts, 2020-2034
4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
5.1. Brand and Pricing Analysis
5.2. Disease Prevalence and Incidence Rate by Region/Countries
5.3. End-user Preference
5.4. Funding and Investment Scenario
5.5. Impact Analysis
5.6. Key Industry Events (Launch, Collaboration, Merger, and Partnership etc.)
5.7. PESTEL Analysis
5.8. Porters Five Forces Analysis
5.9. Regulatory Scenario by Region/Countries
5.10. Technological Advancements
6. Global Preventive Healthcare Technologies and Services Market Analysis and Forecasts, By Service Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Service Type, 2020-2034
6.3.1. Advanced Technologies To Reduce Errors
6.3.1.1. Electronic prescribing
6.3.1.2. Clinical decision supports system
6.3.1.3. Smart infusion pumps
6.3.1.4. Computerized provider order entry system
6.3.1.5. Smart packaging
6.3.1.6. Others (Automated prescription formulation and dispensing, etc.)
6.3.2. Vaccine Administration
6.3.2.1. Flu Vaccine
6.3.2.2. Meningococcal Vaccine
6.3.2.3. Combined Tetanus-Diphtheria-Pertussis Vaccine
6.3.2.4. Human Papillomavirus Vaccine
6.3.2.5. Hepatitis B vaccine
6.3.2.6. Measles, mumps, and rubella (MMR) vaccine
6.3.2.7. Covid-19 Vaccine
6.3.2.8. Others
6.3.3. Early detection and screening technologies
6.3.3.1. Automated screening
6.3.3.2. Personalized medicine
6.3.3.3. Cancer Screening
6.3.4. Chronic disease management technologies
6.3.4.1. Blood pressure monitors
6.3.4.2. Asthma monitors
6.3.4.3. Cardiovascular monitors
6.3.4.4. Glucose monitors
6.4. Market Attractiveness By Service Type
7. Global Preventive Healthcare Technologies and Services Market Analysis and Forecasts, By Technology
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Technology, 2020-2034
7.3.1. Telemedicine
7.3.2. mHealth
7.3.3. Health Information Technology
7.3.4. Wearable Devices
7.3.5. Immunization
7.3.6. Others (At-home test kits, POCT Kits etc.)
7.4. Market Attractiveness By Technology
8. Global Preventive Healthcare Technologies and Services Market Analysis and Forecasts, By Age Group
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Age Group, 2020-2034
8.3.1. Pediatric
8.3.2. Adult
8.3.3. Geriatric
8.4. Market Attractiveness By Age Group
9. Global Preventive Healthcare Technologies and Services Market Analysis and Forecasts, By End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast By End-user, 2020-2034
9.3.1. Hospitals
9.3.2. Healthcare Payers
9.3.3. Clinics
9.3.4. Others (Health check-up camps, specialty centers, etc.)
9.4. Market Attractiveness By End-user
10. Global Preventive Healthcare Technologies and Services Market Analysis and Forecasts, By Region
10.1. Key Findings
10.2. Market Value Forecast By Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness By Country/Region
11. North America Preventive Healthcare Technologies and Services Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Service Type, 2020-2034
11.2.1. Advanced Technologies To Reduce Errors
11.2.1.1. Electronic prescribing
11.2.1.2. Clinical decision supports system
11.2.1.3. Smart infusion pumps
11.2.1.4. Computerized provider order entry system
11.2.1.5. Smart packaging
11.2.1.6. Others (Automated prescription formulation and dispensing, etc.)
11.2.2. Vaccine Administration
11.2.2.1. Flu Vaccine
11.2.2.2. Meningococcal Vaccine
11.2.2.3. Combined Tetanus-Diphtheria-Pertussis Vaccine
11.2.2.4. Human Papillomavirus Vaccine
11.2.2.5. Hepatitis B vaccine
11.2.2.6. Measles, mumps, and rubella (MMR) vaccine
11.2.2.7. Covid-19 Vaccine
11.2.2.8. Others
11.2.3. Early detection and screening technologies
11.2.3.1. Automated screening
11.2.3.2. Personalized medicine
11.2.3.3. Cancer Screening
11.2.4. Chronic disease management technologies
11.2.4.1. Blood pressure monitors
11.2.4.2. Asthma monitors
11.2.4.3. Cardiovascular monitors
11.2.4.4. Glucose monitors
11.3. Market Value Forecast By Technology, 2020-2034
11.3.1. Telemedicine
11.3.2. mHealth
11.3.3. Health Information Technology
11.3.4. Wearable Devices
11.3.5. Immunization
11.3.6. Others (At-home test kits, POCT Kits etc.)
11.4. Market Value Forecast By Age Group, 2020-2034
11.4.1. Pediatric
11.4.2. Adult
11.4.3. Geriatric
11.5. Market Value Forecast By End-user, 2020-2034
11.5.1. Hospitals
11.5.2. Healthcare Payers
11.5.3. Clinics
11.5.4. Others (Health check-up camps, specialty centers, etc.)
11.6. Market Value Forecast By Country, 2020-2034
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Service Type
11.7.2. By Technology
11.7.3. By Age Group
11.7.4. By End-user
11.7.5. By Country
12. Europe Preventive Healthcare Technologies and Services Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Service Type, 2020-2034
12.2.1. Advanced Technologies To Reduce Errors
12.2.1.1. Electronic prescribing
12.2.1.2. Clinical decision supports system
12.2.1.3. Smart infusion pumps
12.2.1.4. Computerized provider order entry system
12.2.1.5. Smart packaging
12.2.1.6. Others (Automated prescription formulation and dispensing, etc.)
12.2.2. Vaccine Administration
12.2.2.1. Flu Vaccine
12.2.2.2. Meningococcal Vaccine
12.2.2.3. Combined Tetanus-Diphtheria-Pertussis Vaccine
12.2.2.4. Human Papillomavirus Vaccine
12.2.2.5. Hepatitis B vaccine
12.2.2.6. Measles, mumps, and rubella (MMR) vaccine
12.2.2.7. Covid-19 Vaccine
12.2.2.8. Others
12.2.3. Early detection and screening technologies
12.2.3.1. Automated screening
12.2.3.2. Personalized medicine
12.2.3.3. Cancer Screening
12.2.4. Chronic disease management technologies
12.2.4.1. Blood pressure monitors
12.2.4.2. Asthma monitors
12.2.4.3. Cardiovascular monitors
12.2.4.4. Glucose monitors
12.3. Market Value Forecast By Technology, 2020-2034
12.3.1. Telemedicine
12.3.2. mHealth
12.3.3. Health Information Technology
12.3.4. Wearable Devices
12.3.5. Immunization
12.3.6. Others (At-home test kits, POCT Kits etc.)
12.4. Market Value Forecast By Age Group, 2020-2034
12.4.1. Pediatric
12.4.2. Adult
12.4.3. Geriatric
12.5. Market Value Forecast By End-user, 2020-2034
12.5.1. Hospitals
12.5.2. Healthcare Payers
12.5.3. Clinics
12.5.4. Others (Health check-up camps, specialty centers, etc.)
12.6. Market Value Forecast By Country, 2020-2034
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Service Type
12.7.2. By Technology
12.7.3. By Age Group
12.7.4. By End-user
12.7.5. By Country
13. Asia Pacific Preventive Healthcare Technologies and Services Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Service Type, 2020-2034
13.2.1. Advanced Technologies To Reduce Errors
13.2.1.1. Electronic prescribing
13.2.1.2. Clinical decision supports system
13.2.1.3. Smart infusion pumps
13.2.1.4. Computerized provider order entry system
13.2.1.5. Smart packaging
13.2.1.6. Others (Automated prescription formulation and dispensing, etc.)
13.2.2. Vaccine Administration
13.2.2.1. Flu Vaccine
13.2.2.2. Meningococcal Vaccine
13.2.2.3. Combined Tetanus-Diphtheria-Pertussis Vaccine
13.2.2.4. Human Papillomavirus Vaccine
13.2.2.5. Hepatitis B vaccine
13.2.2.6. Measles, mumps, and rubella (MMR) vaccine
13.2.2.7. Covid-19 Vaccine
13.2.2.8. Others
13.2.3. Early detection and screening technologies
13.2.3.1. Automated screening
13.2.3.2. Personalized medicine
13.2.3.3. Cancer Screening
13.2.4. Chronic disease management technologies
13.2.4.1. Blood pressure monitors
13.2.4.2. Asthma monitors
13.2.4.3. Cardiovascular monitors
13.2.4.4. Glucose monitors
13.3. Market Value Forecast By Technology, 2020-2034
13.3.1. Telemedicine
13.3.2. mHealth
13.3.3. Health Information Technology
13.3.4. Wearable Devices
13.3.5. Immunization
13.3.6. Others (At-home test kits, POCT Kits etc.)
13.4. Market Value Forecast By Age Group, 2020-2034
13.4.1. Pediatric
13.4.2. Adult
13.4.3. Geriatric
13.5. Market Value Forecast By End-user, 2020-2034
13.5.1. Hospitals
13.5.2. Healthcare Payers
13.5.3. Clinics
13.5.4. Others (Health check-up camps, specialty centers, etc.)
13.6. Market Value Forecast By Country, 2020-2034
13.6.1. China
13.6.2. India
13.6.3. Japan
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Service Type
13.7.2. By Technology
13.7.3. By Age Group
13.7.4. By End-user
13.7.5. By Country
14. Latin America Preventive Healthcare Technologies and Services Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Service Type, 2020-2034
14.2.1. Advanced Technologies To Reduce Errors
14.2.1.1. Electronic prescribing
14.2.1.2. Clinical decision supports system
14.2.1.3. Smart infusion pumps
14.2.1.4. Computerized provider order entry system
14.2.1.5. Smart packaging
14.2.1.6. Others (Automated prescription formulation and dispensing, etc.)
14.2.2. Vaccine Administration
14.2.2.1. Flu Vaccine
14.2.2.2. Meningococcal Vaccine
14.2.2.3. Combined Tetanus-Diphtheria-Pertussis Vaccine
14.2.2.4. Human Papillomavirus Vaccine
14.2.2.5. Hepatitis B vaccine
14.2.2.6. Measles, mumps, and rubella (MMR) vaccine
14.2.2.7. Covid-19 Vaccine
14.2.2.8. Others
14.2.3. Early detection and screening technologies
14.2.3.1. Automated screening
14.2.3.2. Personalized medicine
14.2.3.3. Cancer Screening
14.2.4. Chronic disease management technologies
14.2.4.1. Blood pressure monitors
14.2.4.2. Asthma monitors
14.2.4.3. Cardiovascular monitors
14.2.4.4. Glucose monitors
14.3. Market Value Forecast By Technology, 2020-2034
14.3.1. Telemedicine
14.3.2. mHealth
14.3.3. Health Information Technology
14.3.4. Wearable Devices
14.3.5. Immunization
14.3.6. Others (At-home test kits, POCT Kits etc.)
14.4. Market Value Forecast By Age Group, 2020-2034
14.4.1. Pediatric
14.4.2. Adult
14.4.3. Geriatric
14.5. Market Value Forecast By End-user, 2020-2034
14.5.1. Hospitals
14.5.2. Healthcare Payers
14.5.3. Clinics
14.5.4. Others (Health check-up camps, specialty centers, etc.)
14.6. Market Value Forecast By Country, 2020-2034
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Service Type
14.7.2. By Age Group
14.7.3. By Age Group
14.7.4. By End-user
14.7.5. By Country
15. Middle East & Africa Preventive Healthcare Technologies and Services Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast By Service Type, 2020-2034
15.2.1. Advanced Technologies To Reduce Errors
15.2.1.1. Electronic prescribing
15.2.1.2. Clinical decision supports system
15.2.1.3. Smart infusion pumps
15.2.1.4. Computerized provider order entry system
15.2.1.5. Smart packaging
15.2.1.6. Others (Automated prescription formulation and dispensing, etc.)
15.2.2. Vaccine Administration
15.2.2.1. Flu Vaccine
15.2.2.2. Meningococcal Vaccine
15.2.2.3. Combined Tetanus-Diphtheria-Pertussis Vaccine
15.2.2.4. Human Papillomavirus Vaccine
15.2.2.5. Hepatitis B vaccine
15.2.2.6. Measles, mumps, and rubella (MMR) vaccine
15.2.2.7. Covid-19 Vaccine
15.2.2.8. Others
15.2.3. Early detection and screening technologies
15.2.3.1. Automated screening
15.2.3.2. Personalized medicine
15.2.3.3. Cancer Screening
15.2.4. Chronic disease management technologies
15.2.4.1. Blood pressure monitors
15.2.4.2. Asthma monitors
15.2.4.3. Cardiovascular monitors
15.2.4.4. Glucose monitors
15.3. Market Value Forecast By Technology, 2020-2034
15.3.1. Telemedicine
15.3.2. mHealth
15.3.3. Health Information Technology
15.3.4. Wearable Devices
15.3.5. Immunization
15.3.6. Others (At-home test kits, POCT Kits etc.)
15.4. Market Value Forecast By Age Group, 2020-2034
15.4.1. Pediatric
15.4.2. Adult
15.4.3. Geriatric
15.5. Market Value Forecast By End-user, 2020-2034
15.5.1. Hospitals
15.5.2. Healthcare Payers
15.5.3. Clinics
15.5.4. Others (Health check-up camps, specialty centers, etc.)
15.6. Market Value Forecast By Country, 2020-2034
15.6.1. GCC
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Service Type
15.7.2. By Technology
15.7.3. By Age Group
15.7.4. By End-user
15.7.5. By Country
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of companies)
16.2. Market Share Analysis By Company (2023)
16.3. Company Profiles
16.3.1. Abbott
16.3.1.1. Company Overview
16.3.1.2. Financial Overview
16.3.1.3. Financial Overview
16.3.1.4. Business Strategies
16.3.1.5. Recent Developments
16.3.2. Medtronic
16.3.2.1. Company Overview
16.3.2.2. Financial Overview
16.3.2.3. Financial Overview
16.3.2.4. Business Strategies
16.3.2.5. Recent Developments
16.3.3. GSK plc
16.3.3.1. Company Overview
16.3.3.2. Financial Overview
16.3.3.3. Financial Overview
16.3.3.4. Business Strategies
16.3.3.5. Recent Developments
16.3.4. Omron Healthcare, Inc.
16.3.4.1. Company Overview
16.3.4.2. Financial Overview
16.3.4.3. Financial Overview
16.3.4.4. Business Strategies
16.3.4.5. Recent Developments
16.3.5. Merck and Co. Inc.
16.3.5.1. Company Overview
16.3.5.2. Financial Overview
16.3.5.3. Financial Overview
16.3.5.4. Business Strategies
16.3.5.5. Recent Developments
16.3.6. Pfizer, Inc.
16.3.6.1. Company Overview
16.3.6.2. Financial Overview
16.3.6.3. Financial Overview
16.3.6.4. Business Strategies
16.3.6.5. Recent Developments
16.3.7. Healthways, Inc.
16.3.7.1. Company Overview
16.3.7.2. Financial Overview
16.3.7.3. Financial Overview
16.3.7.4. Business Strategies
16.3.7.5. Recent Developments
16.3.8. Mckesson Corporation
16.3.8.1. Company Overview
16.3.8.2. Financial Overview
16.3.8.3. Financial Overview
16.3.8.4. Business Strategies
16.3.8.5. Recent Developments
16.3.9. Myriad Genetics
16.3.9.1. Company Overview
16.3.9.2. Financial Overview
16.3.9.3. Financial Overview
16.3.9.4. Business Strategies
16.3.9.5. Recent Developments
16.3.10. Novx Systems, Inc
16.3.10.1. Company Overview
16.3.10.2. Financial Overview
16.3.10.3. Financial Overview
16.3.10.4. Business Strategies
16.3.10.5. Recent Developments
16.3.11. Quest Diagnostics Incorporated
16.3.11.1. Company Overview
16.3.11.2. Financial Overview
16.3.11.3. Financial Overview
16.3.11.4. Business Strategies
16.3.11.5. Recent Developments
16.3.12. Other prominent players
16.3.12.1. Company Overview
16.3.12.2. Financial Overview
16.3.12.3. Financial Overview
16.3.12.4. Business Strategies
16.3.12.5. Recent Developments
List of Tables
Table 01: Global Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Service Type, 2020-2034
Table 02: Global Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Advanced Technologies to Reduce Errors, 2020-2034
Table 03: Global Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Vaccine Administration, 2020-2034
Table 04: Global Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Early detection and screening technologies, 2020-2034
Table 05: Global Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Chronic disease management technologies, 2020-2034
Table 06: Global Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Technology, 2020-2034
Table 07: Global Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Age Group, 2020-2034
Table 08: Global Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By End-user, 2020-2034
Table 09: North America - Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, by Country, 2020-2034
Table 10: North America Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Service Type, 2020-2034
Table 11: North America Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Advanced Technologies to Reduce Errors, 2020-2034
Table 12: North America Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Vaccine Administration, 2020-2034
Table 13: North America Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Early detection and screening technologies, 2020-2034
Table 14: North America Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Chronic disease management technologies, 2020-2034
Table 15: North America Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Technology, 2020-2034
Table 16: North America Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Age Group, 2020-2034
Table 17: North America Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By End-user, 2020-2034
Table 18: Europe - Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, by Country, 2020-2034
Table 19: Europe Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Service Type, 2020-2034
Table 20: Europe Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Advanced Technologies to Reduce Errors, 2020-2034
Table 21: Europe Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Vaccine Administration, 2020-2034
Table 22: Europe Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Early detection and screening technologies, 2020-2034
Table 23: Europe Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Chronic disease management technologies, 2020-2034
Table 24: Europe Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Technology, 2020-2034
Table 25: Europe Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Age Group, 2020-2034
Table 26: Europe Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By End-user, 2020-2034
Table 27: Asia Pacific - Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, by Country, 2020-2034
Table 28: Asia Pacific Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Service Type, 2020-2034
Table 29: Asia Pacific Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Advanced Technologies to Reduce Errors, 2020-2034
Table 30: Asia Pacific Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Vaccine Administration, 2020-2034
Table 31: Asia Pacific Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Early detection and screening technologies, 2020-2034
Table 32: Asia Pacific Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Chronic disease management technologies, 2020-2034
Table 33: Asia Pacific Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Technology, 2020-2034
Table 34: Asia Pacific Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Age Group, 2020-2034
Table 35: Asia Pacific Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By End-user, 2020-2034
Table 36: Latin America - Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, by Country, 2020-2034
Table 37: Latin America Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Service Type, 2020-2034
Table 38: Latin America Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Advanced Technologies to Reduce Errors, 2020-2034
Table 39: Latin America Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Vaccine Administration, 2020-2034
Table 40: Latin America Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Early detection and screening technologies, 2020-2034
Table 41: Latin America Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Chronic disease management technologies, 2020-2034
Table 42: Latin America Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Technology, 2020-2034
Table 43: Latin America Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Age Group, 2020-2034
Table 44: Latin America Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By End-user, 2020-2034
Table 45: Middle East & Africa - Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, by Country, 2020-2034
Table 46: Middle East & Africa Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Service Type, 2020-2034
Table 47: Middle East & Africa Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Advanced Technologies to Reduce Errors, 2020-2034
Table 48: Middle East & Africa Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Vaccine Administration, 2020-2034
Table 49: Middle East & Africa Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Early detection and screening technologies, 2020-2034
Table 50: Latin America Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Chronic disease management technologies, 2020-2034
Table 51: Middle East & Africa Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Technology, 2020-2034
Table 52: Middle East & Africa Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By Age Group, 2020-2034
Table 53: Middle East & Africa Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, By End-user, 2020-2034
List of Figures
Figure 01: Global Preventive Healthcare Technologies and Services Market Value Share Analysis, By Service Type, 2023 and 2034
Figure 02: Global Preventive Healthcare Technologies and Services Market Attractiveness Analysis, By Service Type, 2024-2034
Figure 03: Global Preventive Healthcare Technologies and Services Market Revenue (US$ Bn), by Advanced Technologies to Reduce Errors, 2020-2034
Figure 04: Global Preventive Healthcare Technologies and Services Market Revenue (US$ Bn), by Vaccine Administration, 2020-2034
Figure 05: Global Preventive Healthcare Technologies and Services Market Revenue (US$ Bn), by Early detection and screening technologies, 2020-2034
Figure 06: Global Preventive Healthcare Technologies and Services Market Revenue (US$ Bn), by Chronic disease management technologies, 2020-2034
Figure 07: Global Preventive Healthcare Technologies and Services Market Value Share Analysis, By Technology, 2023 and 2034
Figure 08: Global Preventive Healthcare Technologies and Services Market Attractiveness Analysis, By Technology, 2024-2034
Figure 09: Global Preventive Healthcare Technologies and Services Market Revenue (US$ Bn), by Telemedicine, 2020-2034
Figure 10: Global Preventive Healthcare Technologies and Services Market Revenue (US$ Bn), by mHealth, 2020-2034
Figure 11: Global Preventive Healthcare Technologies and Services Market Revenue (US$ Bn), by Health Information Technology, 2020-2034
Figure 12: Global Preventive Healthcare Technologies and Services Market Revenue (US$ Bn), by Wearable Devices, 2020-2034
Figure 13: Global Preventive Healthcare Technologies and Services Market Revenue (US$ Bn), by Immunization, 2020-2034
Figure 14: Global Preventive Healthcare Technologies and Services Market Revenue (US$ Bn), by Others, 2020-2034
Figure 15: Global Preventive Healthcare Technologies and Services Market Value Share Analysis, By Age Group, 2023 and 2034
Figure 16: Global Preventive Healthcare Technologies and Services Market Attractiveness Analysis, By Age Group, 2024-2034
Figure 17: Global Preventive Healthcare Technologies and Services Market Revenue (US$ Bn), by Pediatric, 2020-2034
Figure 18: Global Preventive Healthcare Technologies and Services Market Revenue (US$ Bn), by Adult, 2020-2034
Figure 19: Global Preventive Healthcare Technologies and Services Market Revenue (US$ Bn), by Geriatric, 2020-2034
Figure 20: Global Preventive Healthcare Technologies and Services Market Value Share Analysis, By End-user, 2023 and 2034
Figure 21: Global Preventive Healthcare Technologies and Services Market Attractiveness Analysis, By End-user, 2024-2034
Figure 22: Global Preventive Healthcare Technologies and Services Market Revenue (US$ Bn), by Hospitals, 2020-2034
Figure 23: Global Preventive Healthcare Technologies and Services Market Revenue (US$ Bn), by Healthcare Payers, 2020-2034
Figure 24: Global Preventive Healthcare Technologies and Services Market Revenue (US$ Bn), by Clinics, 2020-2034
Figure 25: Global Preventive Healthcare Technologies and Services Market Revenue (US$ Bn), by Others, 2020-2034
Figure 26: North America Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, 2020-2034
Figure 27: North America Preventive Healthcare Technologies and Services Market Value Share Analysis, by Country, 2023 and 2034
Figure 28: North America Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Country, 2024-2034
Figure 29: North America Preventive Healthcare Technologies and Services Market Value Share Analysis, By Service Type, 2023 and 2034
Figure 30: North America Preventive Healthcare Technologies and Services Market Attractiveness Analysis, By Service Type, 2024-2034
Figure 31: North America Preventive Healthcare Technologies and Services Market Value Share Analysis, By Technology, 2023 and 2034
Figure 32: North America Preventive Healthcare Technologies and Services Market Attractiveness Analysis, By Technology, 2024-2034
Figure 33: North America Preventive Healthcare Technologies and Services Market Value Share Analysis, By Age Group, 2023 and 2034
Figure 34: North America Preventive Healthcare Technologies and Services Market Attractiveness Analysis, By Age Group, 2024-2034
Figure 35: North America Preventive Healthcare Technologies and Services Market Value Share Analysis, By End-user, 2023 and 2034
Figure 36: North America Preventive Healthcare Technologies and Services Market Attractiveness Analysis, By End-user, 2024-2034
Figure 37: Europe Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, 2020-2034
Figure 38: Europe Preventive Healthcare Technologies and Services Market Value Share Analysis, by Country, 2023 and 2034
Figure 39: Europe Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Country, 2024-2034
Figure 40: Europe Preventive Healthcare Technologies and Services Market Value Share Analysis, By Service Type, 2023 and 2034
Figure 41: Europe Preventive Healthcare Technologies and Services Market Attractiveness Analysis, By Service Type, 2024-2034
Figure 42: Europe Preventive Healthcare Technologies and Services Market Value Share Analysis, By Technology, 2023 and 2034
Figure 43: Europe Preventive Healthcare Technologies and Services Market Attractiveness Analysis, By Technology, 2024-2034
Figure 44: Europe Preventive Healthcare Technologies and Services Market Value Share Analysis, By Age Group, 2023 and 2034
Figure 45: Europe Preventive Healthcare Technologies and Services Market Attractiveness Analysis, By Age Group, 2024-2034
Figure 46: Europe Preventive Healthcare Technologies and Services Market Value Share Analysis, By End-user, 2023 and 2034
Figure 47: Europe Preventive Healthcare Technologies and Services Market Attractiveness Analysis, By End-user, 2024-2034
Figure 48: Asia Pacific Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, 2020-2034
Figure 49: Asia Pacific Preventive Healthcare Technologies and Services Market Value Share Analysis, by Country, 2023 and 2034
Figure 50: Asia Pacific Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Country, 2024-2034
Figure 51: Asia Pacific Preventive Healthcare Technologies and Services Market Value Share Analysis, By Service Type, 2023 and 2034
Figure 52: Asia Pacific Preventive Healthcare Technologies and Services Market Attractiveness Analysis, By Service Type, 2024-2034
Figure 53: Asia Pacific Preventive Healthcare Technologies and Services Market Value Share Analysis, By Technology, 2023 and 2034
Figure 54: Asia Pacific Preventive Healthcare Technologies and Services Market Attractiveness Analysis, By Technology, 2024-2034
Figure 55: Asia Pacific Preventive Healthcare Technologies and Services Market Value Share Analysis, By Age Group, 2023 and 2034
Figure 56: Asia Pacific Preventive Healthcare Technologies and Services Market Attractiveness Analysis, By Age Group, 2024-2034
Figure 57: Asia Pacific Preventive Healthcare Technologies and Services Market Value Share Analysis, By End-user, 2023 and 2034
Figure 58: Asia Pacific Preventive Healthcare Technologies and Services Market Attractiveness Analysis, By End-user, 2024-2034
Figure 59: Latin America Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, 2020-2034
Figure 60: Latin America Preventive Healthcare Technologies and Services Market Value Share Analysis, by Country, 2023 and 2034
Figure 61: Latin America Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Country, 2024-2034
Figure 62: Latin America Preventive Healthcare Technologies and Services Market Value Share Analysis, By Service Type, 2023 and 2034
Figure 63: Latin America Preventive Healthcare Technologies and Services Market Attractiveness Analysis, By Service Type, 2024-2034
Figure 64: Latin America Preventive Healthcare Technologies and Services Market Value Share Analysis, By Technology, 2023 and 2034
Figure 65: Latin America Preventive Healthcare Technologies and Services Market Attractiveness Analysis, By Technology, 2024-2034
Figure 66: Latin America Preventive Healthcare Technologies and Services Market Value Share Analysis, By Age Group, 2023 and 2034
Figure 67: Latin America Preventive Healthcare Technologies and Services Market Attractiveness Analysis, By Age Group, 2024-2034
Figure 68: Latin America Preventive Healthcare Technologies and Services Market Value Share Analysis, By End-user, 2023 and 2034
Figure 69: Latin America Preventive Healthcare Technologies and Services Market Attractiveness Analysis, By End-user, 2024-2034
Figure 70: Middle East & Africa Preventive Healthcare Technologies and Services Market Value (US$ Bn) Forecast, 2020-2034
Figure 71: Middle East & Africa Preventive Healthcare Technologies and Services Market Value Share Analysis, by Country, 2023 and 2034
Figure 72: Middle East & Africa Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Country, 2024-2034
Figure 73: Middle East & Africa Preventive Healthcare Technologies and Services Market Value Share Analysis, By Service Type, 2023 and 2034
Figure 74: Middle East & Africa Preventive Healthcare Technologies and Services Market Attractiveness Analysis, By Service Type, 2024-2034
Figure 75: Middle East & Africa Preventive Healthcare Technologies and Services Market Value Share Analysis, By Technology, 2023 and 2034
Figure 76: Middle East & Africa Preventive Healthcare Technologies and Services Market Attractiveness Analysis, By Technology, 2024-2034
Figure 77: Middle East & Africa Preventive Healthcare Technologies and Services Market Value Share Analysis, By Age Group, 2023 and 2034
Figure 78: Middle East & Africa Preventive Healthcare Technologies and Services Market Attractiveness Analysis, By Age Group, 2024-2034
Figure 79: Middle East & Africa Preventive Healthcare Technologies and Services Market Value Share Analysis, By End-user, 2023 and 2034
Figure 80: Middle East & Africa Preventive Healthcare Technologies and Services Market Attractiveness Analysis, By End-user, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Preventive Healthcare Technologies and Services Market
